|
Synarc’s medical directors are leading authorities in the use of medical imaging and biochemical markers in drug development. They have pioneered many of the applications currently used in clinical trials of rheumatoid arthritis, and understand how to implement these techniques properly in large scale multi-center studies. Please feel free to contact them directly for advice about your program.
|
